PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 11, 2026ChemistrySelect0 citations

Enrichment of Vitexin and Isovitexin From Santalum album L. Leaves and Evaluation of Their In Vitro and In Vivo Biological Activities

View Full Paper
PPPhan Thi Kim PhungLQLe Minh QuanDHDo Hoang Han

Key Points

  • The research aims to develop a simple method for enriching vitexin and isovitexin from Santalum album leaves and assess their biological activities.
  • Employed biphasic partitioning with n-hexane and water for extraction.
  • Used cold-water recrystallization for purification.
  • Conducted UHPLC analysis to quantify vitexin and isovitexin concentrations.
  • Performed acute and sub-acute toxicological assessments in mice.
  • Evaluated biological activities including enzyme inhibition and antioxidant assays.
  • Achieved 6.1-fold increase in vitexin and isovitexin concentration compared to hydroethanolic extract.
  • Demonstrated moderate inhibition of α-glucosidase and α-amylase enzymes.
  • Exhibited significant antioxidant activity in DPPH and ABTS assays.
  • Showed blood glucose reduction of 43.2% in diabetic mice without adverse effects.
  • Proven safety with an LD50 greater than 2.5 g/kg in toxicity studies.

Abstract

ABSTRACT Vitexin and isovitexin are flavonoids with diverse pharmacological properties; however, their enrichment usually relies on chromatographic techniques, which are labor‐intensive and costly. This study reports, for the first time, a simple and chromatography‐free method to prepare a vitexin‐ and isovitexin‐enriched extract (VIEE) from Santalum album L. leaves. The method involved (i) biphasic partitioning between n‐hexane and water, followed by (ii) cold‐water recrystallization. UHPLC analysis confirmed that VIEE contained 456.038 mg/g vitexin and 221.422 mg/g isovitexin (67.75% total), corresponding to a 6.1‐fold increase compared with the hydroethanolic extract. Toxicological assessment demonstrated high safety, with LD 50 > 2.5 g/kg and no adverse effects in a 28‐day sub‐acute study at doses up to 900 mg/kg. Biologically, VIEE exhibited moderate inhibition of α‐glucosidase and α‐amylase , potent antioxidant activity in DPPH and ABTS assays, and acetylcholinesterase inhibition comparable to berberine. In streptozotocin‐induced diabetic mice, VIEE (300 mg/kg) lowered blood glucose by 43.2% after 14 days, prevented weight loss, and showed efficacy comparable to glibenclamide (47.9% reduction), while not affecting normoglycemic mice. Overall, this study introduces a cost‐effective, scalable enrichment strategy that adds value to S. album leaves and supports their development as a safe, multi‐target phytopharmaceutical for diabetes management.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Phung et al. (2026) studied this question.

synapsesocial.com/papers/69d9e63478050d08c1b768cdhttps://doi.org/10.1002/slct.202505695
Ask AI
Helpful
Bookmark
Share
View Full Paper